医学
无容量
多西紫杉醇
肺癌
肿瘤科
内科学
癌症
免疫疗法
作者
H. Borghaei,L. Paz-Ares,Leora Horn,David R. Spigel,Martin Steins,Neal Ready,Laura Q.M. Chow,Everett E. Vokes,Enriqueta Felip,Esther Holgado,Fabrice Barlési,M. Kohlhufl,Óscar Arrieta,M. Burgio,Jérôme Fayette,H. Lena,Elena Poddubskaya,David E. Gerber,Scott Gettinger,Charles M. Rudin
标识
DOI:10.1056/nejmoa1507643
摘要
Nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, disrupts PD-1-mediated signaling and may restore antitumor immunity.
科研通智能强力驱动
Strongly Powered by AbleSci AI